• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo.

Pam Belluck
Author: Pam Belluck

Written by

Pam Belluck

in

Clinical Trials, Corporations, Drugs (Pharmaceuticals), Suits and Litigation (Civil)
←A Racially Biased Test That Prevented Thousands Of Black People From Receiving Kidney Transplants Is Finally Changing
Reworked Italian Jerseys That Celebrate Soccer Style→

More posts

  • Senate GOP Armed Services chair: ‘Time is over’ for talks with Iran

  • Ellen DeGeneres Returning To Voice Dory In New Short Out Of Pixar’s ‘Finding Nemo’ Universe

  • US imposes sanctions targeting Iran’s oil network in China

  • As Trump inspector general nominee waits in wings, Epstein files audit draws muted praise

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube